检索结果 - Anna Asklid
- Showing 1 - 5 results of 5
-
1
-
2
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A st... 由 Maria Winqvist, Anna Asklid, PO Andersson, Karin Karlsson, Claes Karlsson, Birgitta Lauri, Jeanette Lundin, Mattias Mattsson, Stefan Norin, Anna Sandstedt, Lotta Hansson, Anders Österborg
发表在 Haematologica (2016-12-01)获取全文
文件 -
3
Why are not all paediatric cancer patients treated with protons? A population-based report from Sweden, 2016–2023 由 Anna Asklid, Ingrid Kristensen, Ulla Martinsson, Martin Nilsson, Malin Blomstrand, Måns Agrup, Anna Flejmer, Anna-Maja Svärd, Charlotta Fröjd, Erik Almhagen, Jacob Engellau, Anna Embring
发表在 Acta Oncologica (2025-09-01)获取全文
文件 -
4
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort 由 Maria Winqvist, Per-Ola Andersson, Anna Asklid, Karin Karlsson, Claes Karlsson, Birgitta Lauri, Jeanette Lundin, Mattias Mattsson, Stefan Norin, Anna Sandstedt, Richard Rosenquist, Florentin Späth, Lotta Hansson, Anders Österborg, for the Swedish CLL Group
发表在 Haematologica (2019-05-01)获取全文
文件 -
5
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013 由 Sandra Eketorp Sylvan, Anna Asklid, Hemming Johansson, Jenny Klintman, Jenny Bjellvi, Staffan Tolvgård, Eva Kimby, Stefan Norin, Per-Ola Andersson, Claes Karlsson, Karin Karlsson, Birgitta Lauri, Mattias Mattsson, Anna Bergendahl Sandstedt, Maria Strandberg, Anders Österborg, Lotta Hansson
发表在 Haematologica (2019-04-01)获取全文
文件